Nothing Special   »   [go: up one dir, main page]

PT99513A - Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica

Info

Publication number
PT99513A
PT99513A PT99513A PT9951391A PT99513A PT 99513 A PT99513 A PT 99513A PT 99513 A PT99513 A PT 99513A PT 9951391 A PT9951391 A PT 9951391A PT 99513 A PT99513 A PT 99513A
Authority
PT
Portugal
Prior art keywords
pct
profarmacas
transdermic
preparation
pharmaceutical compositions
Prior art date
Application number
PT99513A
Other languages
English (en)
Other versions
PT99513B (pt
Inventor
Hans Bundgaard
Lona Christrup
Jorn Drustrup
Ann Fullerton
Martin Nicklasson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of PT99513A publication Critical patent/PT99513A/pt
Publication of PT99513B publication Critical patent/PT99513B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT99513A 1990-11-16 1991-11-14 Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica PT99513B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs

Publications (2)

Publication Number Publication Date
PT99513A true PT99513A (pt) 1992-09-30
PT99513B PT99513B (pt) 1999-04-30

Family

ID=20380936

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99513A PT99513B (pt) 1990-11-16 1991-11-14 Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica

Country Status (18)

Country Link
US (1) US5908846A (pt)
EP (1) EP0557385B1 (pt)
JP (1) JP3493434B2 (pt)
AT (1) ATE168560T1 (pt)
AU (1) AU655612B2 (pt)
CA (1) CA2095223C (pt)
DE (1) DE69129861T2 (pt)
DK (1) DK0557385T3 (pt)
ES (1) ES2121793T3 (pt)
FI (1) FI932212A (pt)
IE (1) IE913682A1 (pt)
IL (1) IL99905A (pt)
NO (1) NO931766L (pt)
NZ (1) NZ240349A (pt)
PT (1) PT99513B (pt)
SE (1) SE9003665D0 (pt)
WO (1) WO1992008459A1 (pt)
ZA (1) ZA918512B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
JPH07267862A (ja) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd 経皮吸収貼付剤
DE19508664C2 (de) * 1995-03-14 2001-08-23 Christian Mignat Verwendung von Morphin-3-estern, Morphin-3-ester als solche und Verfahren zu deren Herstellung
AU5108596A (en) * 1995-03-14 1996-10-02 Mundipharma Gmbh Morphine-3-esters
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19602969A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN107213128A (zh) 1999-10-29 2017-09-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
KR100968128B1 (ko) 2000-10-30 2010-07-06 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US6569449B1 (en) * 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
BRPI0115953B8 (pt) * 2000-11-14 2021-05-25 Vital Health Sciences Pty Ltd complexos de derivados de fosfato
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
NZ529661A (en) * 2001-06-05 2006-03-31 Control Delivery Systems Sustained-release analgesic compounds
CA2453823C (en) * 2001-07-27 2010-12-21 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
EP1460995B1 (en) * 2001-12-13 2010-11-10 Vital Health Sciences Pty Ltd. Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
ATE444296T1 (de) * 2002-10-25 2009-10-15 Euro Celtique Sa Analoga und prodrugs von buprenorphin
WO2004043396A2 (en) * 2002-11-09 2004-05-27 Nobex Corporation Modified carbamate-containing prodrugs and methods of synthesizing same
ATE534384T1 (de) * 2003-01-17 2011-12-15 Vital Health Sciences Pty Ltd Verbindungen mit proliferationshemmenden eigenschaften
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
ATE382354T1 (de) * 2003-07-25 2008-01-15 Euro Celtique Sa Präoperative behandlung von postoperativen schmerzen
US8003793B2 (en) 2004-02-06 2011-08-23 Purdue Pharma L.P. Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates
PT2074989E (pt) 2004-02-23 2014-02-06 Euro Celtique Sa Dispositivo de administração transdérmica de opióides com resistência ao abuso
US20060281716A1 (en) * 2004-03-03 2006-12-14 West Simon M Alkaloid formulations
EP2548581A3 (en) * 2005-06-17 2013-02-20 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
JP2009520697A (ja) * 2005-12-23 2009-05-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド サイトカイン調節性を有する化合物
CN101621999B (zh) 2007-03-02 2012-09-26 帝化制药株式会社 经皮吸收医药组合物、医药组合物储存单元以及利用了该储存单元的经皮吸收制剂
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20100104614A1 (en) * 2008-06-27 2010-04-29 Oronsky Bryan T Providone compositions for wound healing
WO2011002995A1 (en) * 2009-07-02 2011-01-06 Kempharm, Inc. Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
UA102916C2 (uk) * 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
US10849981B2 (en) 2009-07-02 2020-12-01 KemPham, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
TWI507193B (zh) 2010-03-30 2015-11-11 Phosphagenics Ltd 經皮輸送貼劑
KR20150036825A (ko) 2010-04-13 2015-04-07 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
KR20190049944A (ko) 2014-11-25 2019-05-09 켐팜 인코포레이티드 옥시코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트
WO2017096427A1 (en) 2015-12-09 2017-06-15 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
ES2094809T3 (es) * 1990-03-30 1997-02-01 Yasunori Morimoto Composicion absorbible por via percutanea del clorhidrato de morfina.
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine

Also Published As

Publication number Publication date
IE913682A1 (en) 1992-05-20
DE69129861D1 (de) 1998-08-27
EP0557385B1 (en) 1998-07-22
ATE168560T1 (de) 1998-08-15
IL99905A0 (en) 1992-08-18
WO1992008459A1 (en) 1992-05-29
JP3493434B2 (ja) 2004-02-03
PT99513B (pt) 1999-04-30
AU655612B2 (en) 1995-01-05
JPH06502422A (ja) 1994-03-17
SE9003665D0 (sv) 1990-11-16
NZ240349A (en) 1993-07-27
ES2121793T3 (es) 1998-12-16
DK0557385T3 (da) 1999-04-26
NO931766D0 (no) 1993-05-14
IL99905A (en) 1995-06-29
ZA918512B (en) 1992-08-26
FI932212A0 (fi) 1993-05-14
CA2095223A1 (en) 1992-05-17
EP0557385A1 (en) 1993-09-01
AU8938191A (en) 1992-06-11
FI932212A (fi) 1993-05-14
CA2095223C (en) 2002-12-17
NO931766L (no) 1993-05-14
US5908846A (en) 1999-06-01
DE69129861T2 (de) 1999-04-01

Similar Documents

Publication Publication Date Title
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR9406779A (pt) Complexos de inclusão de multicomponentes altamente solúveis contendo uma droga de tipo básico um ácido e uma ciclodextrina
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
PT90308A (pt) Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE120180T1 (de) 4,5-dihydroxy und 4,5,8-trihydroxy-9,10-dioxo-2- anthracencarbonsäure-dikohlensäureester und urethane mit therapeutischer wirkung.
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
EP0335446A3 (en) Agents for treating neoplasms
GB9015774D0 (en) Novel treatment
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920525

FG3A Patent granted, date of granting

Effective date: 19990126

MM3A Annulment or lapse

Effective date: 20060726